Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now? - Wikidata - thesis-toulmin - TriplyDB

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

http://www.wikidata.org/entity/Q37080510

about

Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis Radiation induced pulmonary fibrosis as a model of progressive fibrosis: Contributions of DNA damage, inflammatory response and cellular senescence genes.Targeting sphingosine-1-phosphate signaling in lung diseases.Toward an antifibrotic therapy for inflammatory bowel disease Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.Therapeutic targets in fibrotic pathways.Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update.Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants.p38α: A Profibrotic Signaling Nexus.

P2860

Q33735530-6070D272-31E7-4A6B-88CA-D6A575DAF351 Q38769339-F729A413-427E-4D6C-AB1F-B443F3BAF8C8 Q38952840-067D1386-C895-4CE2-BFC4-C14848199B5E Q42383547-3015D251-2D5B-46E6-88C7-CB1D83BA7031 Q46387801-D5A5507E-C699-4EA5-89A9-5D74017C5335 Q46625101-041912B9-2E18-4C75-A77B-F4B895535536 Q47361127-4512468E-B30C-451C-AE5E-BB9AE511D0B5 Q52659102-9A2A8ED1-9BF1-493A-B114-92117839BF5C Q53723126-83B9BCFE-409A-4BE2-A450-98D6FB48E6C2

P2860

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

http://www.wikidata.org/entity/Q37080510

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

@en

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

@nl

type

label

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

@en

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

@nl

prefLabel

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

@en

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

@nl

P1433

Q37080510-B397E88E-8E7E-49D4-B3EF-B663EE6B04BD

P1476

Q37080510-F786A91E-B53D-4EF9-8F11-1B6250956D22

P2093

Q37080510-0696C440-EB9B-413B-9CBE-092B8178EAF8

Q37080510-8147CEA4-F54D-42A2-9209-3FF3425A586A

P2860

Q37080510-00D2B93F-7E45-41D7-8047-99108EFAC606

Q37080510-050468D7-BADB-4237-BD23-640D5F4B7BF1

Q37080510-05267CC4-C505-4124-8220-BCA54A430920

Q37080510-063B3C58-037F-4693-8FB1-A7D4D5D5DD8B

Q37080510-08CE5EEA-F79D-45AA-AF8D-A493952EDF09

Q37080510-0EBBF070-0A2F-4F6F-A04F-023FB8D1B32F

Q37080510-10761996-1EFA-4859-AF47-DA20D9AA010C

Q37080510-109E4B77-688C-41FD-A12C-AF0581AA68A1

Q37080510-1D75D2A3-7197-4FA1-B181-709EA33DC1F5

Q37080510-209EEC09-00D5-41D3-B914-267DFB4CB046

P2888

Q37080510-B7E7C51A-22D3-425F-B59B-00ADEBC76C47

P304

Q37080510-2758FF92-2FCA-40D1-B59B-DFADA9B97170

P31

Q37080510-E9C3DCB7-C480-405B-A5F4-44447F7CAA34

P356

Q37080510-1E81716F-6BA0-4C05-96ED-BCD3C49613BD

P433

Q37080510-1AA782B4-87E3-494E-9F0E-A8C8327ED8ED

P478

Q37080510-8150CA84-BBA6-4567-BDB7-21878565538C

P50

Q37080510-1FFEB523-C16E-4793-97ED-3877B7114F09

Q37080510-933EC472-95B2-4A7C-B31D-9063D5D82443

P577

Q37080510-18EB7DC3-8E21-4448-B775-B8D90CFF65C4

P698

Q37080510-0FC15C7B-F3EA-479A-BAB9-ACE2A27B3034

P921

Q37080510-90E6F5E6-26AA-4ECA-871F-CF46A7E1C817

P932

Q37080510-53F7DBAA-E374-4423-BC63-95115F3CE3E7

P356

S40265-015-0523-6

P1433

P1476

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

@en

P2093

Tracy R Luckhardt

http://www.w3.org/2001/XMLSchema#string

Victor J Thannickal

http://www.w3.org/2001/XMLSchema#string

P2860

The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation

Rocks: multifunctional kinases in cell behaviour

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

Rho kinase proteins--pleiotropic modulators of cell survival and apoptosis

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy

Mammalian microRNAs predominantly act to decrease target mRNA levels

MicroRNAs: genomics, biogenesis, mechanism, and function

The hallmarks of aging

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

P2888

s40265-015-0523-6

P304

291-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-015-0523-6

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Sunad Rangarajan

P577

2016-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26729185

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

4939080

http://www.w3.org/2001/XMLSchema#string